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Introduction
Avian influenza (AI) infections are carefully monitored because of their negative effects on intensive poultry rearing systems, but also in view of occasional diseases in humans and fear for pandemic spreading. Our understanding of in vivo influenza pathogenesis and host immunity is limited, despite considerable experimental knowledge generated mainly in mouse and ferret models. As chickens are natural hosts for respiratory influenza infections, understanding influenza immunity in its host is not only an important issue in the poultry industry, but may also provide key insights into immune pathways required for prophylactic or therapeutic protection of other influenza hosts, and possibly even against other respiratory viruses.
Antiviral protection generally requires an orchestration of innate, and if necessary, adaptive immune cells. The tools to study immunological responses in chicken are limited when compared to those available in the mouse and human system. Recently, we and others have identified and cloned the genes that encode novel immunoregulatory response modifiers of the chicken [1] [2] [3] [4] which, in general, show limited sequence homology to known mammalian genes. In addition, numerous chicken gene sequences are now available through the recently assembled chicken genome [5] . These sequence data allow analysis at the transcriptional level of potential immunorelevant molecules, although the effect of posttranslational gene expression cannot be measured and secure functional annotation requires confirmation in future investigations.
For the chicken study described in this paper we used the avian influenza A subtype H9N2 (isolate A/Chicken/United Arab Emirates/99). This serotype is pathotyped as low pathogenic, according to the OIE classification and certified by CVL Weybridge, but is able to produce a severe infection in the context of opportunistic secondary pathogens, such as infectious bronchitis virus (IBV) or Mycoplasma gallisepticum [6] . On the other hand, it was shown that H9N2 viruses evoked cross-protective CTL-based cellular immunity in chickens against a highly pathogenic H5N1 infection [7, 8] . Influenza A virus is a member of the Orthomyxoviridae family of segmented, negative-stranded RNA viruses. Avian influenza A subtype H9N2 viruses can transmit to mammalian species, including humans [9, 10] . Its transmission to humans, combined with genetic reassortment or mutation, raised anxiety for a potential pandemic spread in the human population [11, 12] .
Apart from classical assays, such as histopathology and antiviral antibody titers, we analyzed gene expression profiles, using a newly designed chicken immune-microarray [13] . With this cDNA microarray we studied host gene expression in the lungs and spleen of non-immune (mockimmunized), immune (immunized with inactivated H9N2 antigen in saline), and immune potentiated (immunized with inactivated H9N2 in a water-in-oil emulsion) chickens undergoing a primary respiratory infection with live H9N2. We questioned whether lung pathology and immunity-associated gene pathways could be identified in non-immune birds and whether they (partially) overlap with those in primed birds. We also aimed to identify primed memory immune pathways in immune and immune potentiated animals and questioned whether they differ from natural immune pathways in infected non-immune birds. In addition we tested whether viral replication was affected by immunization.
From our study we conclude that immune potentiated birds developed inhibitory antiviral antibodies, showed minimal lung histopathology and no detectable viral sequences, while non-immune animals showed microscopic immunopathology and detectable virus. Immune birds, receiving antigen in saline only, showed minimal overall microscopic histopathology, and intermediate levels of virus detection. These classical features were compared with host mRNA gene expression profiles in lungs and spleen using microarray analysis.
Materials and methods

Animals
Three-week-old chickens (S5 inbred broiler type) were derived from Hybro/Euribrid (Boxmeer, the Netherlands) and housed under SPF conditions. The animals received food and water ad libitum. In compliance with the Dutch law, all experiments were carried out according to protocols approved by the Intervet Animal Welfare Committee.
H9N2 virus and antigen preparation
Avian influenza A subtype H9N2 virus (isolate A/Chicken/United Arab Emirates/99) was produced in eggs using routine procedures. For the experimental vaccine formulation the aqueous phase containing the virus suspension, diluted in 0.01 M phosphate buffer (pH 7.2), was formalininactivated. This formalin-inactivated antigen preparation was formulated into saline or into an immunopotentiating mineral oil-based W/O emulsion according to standard procedures using a high speed mixing device (ultra-thurrax) [14] .
Experimental immunization protocol
Distinct groups (n = 3) of 3-week-old chickens were i.m. vaccinated in the leg muscle (see also Table 1 ) with either 0.25 ml saline (naive and non-immune control groups), with 0.25 ml formalin inactivated avian influenza H9N2 antigen in saline (immune group), or with inactivated avian influenza H9N2 antigen formulated in an immunopotentiating mineral oil-based W/O emulsion (45/55, v/v) (immune potentiated group). Blood samples were taken at 0 and 3 weeks post-vaccination. At 3 weeks post-vaccination all groups, except the naive control group, were infected (challenged) via the oculo-nasal plus intratracheal route with a total dose of 10e8.8 ED50 H9N2 virus (i.e. 0.1 ml/eye, 0.1 ml/nostril, 0.2 ml into the trachea). At 1 and 5 days post-infection chickens were sacrificed and the lungs and spleens were isolated for histopathology and RNA isolation (see also Fig. 1 for a time scheme).
HI-assay for antiviral H9-antibodies
Serum levels of H9-specific antibodies were determined by a haemagglutination inhibition (HI) assay. Serial two-fold serum dilutions were prepared in microtiter plates and mixed with an equal volume containing eight haemagglutinating units/50 l H9N2 antigen. Titers are expressed as the reciprocal of the highest dilution that gives complete inhibition of haemagglutination of chicken red blood cells (1%, v/v in buffered saline). Samples were regarded positive for inhibition of haemagglutination at a dilution ≥1:2. 
Histopathology
Histopathological evaluation was performed by a certified and well-trained pathologist on haematoxylin-eosin (HE)-stained 5 m paraffin sections of formalin-fixed lung tissue fragments dissected at 1 and 5 days post-infection from naive, non-immune, immune and immune potentiated chickens.
RNA isolation
Total RNA was isolated from lung and spleen samples using a Trizol extraction method as described by the manufacturer (Invitrogen Life Technologies, Paisley, UK) and subsequently purified using the RNeasy Midi RNA Purification kit (Qiagen Ltd., Crawley, UK). The RNA concentration was determined spectrophotometrically and its quality by using the Agilent 2100 Bioanalyser (Agilent Technologies, Waldbronn, Germany). RNA was treated with DNaseI as described by the manufacturer (Ambion Ltd., Huntingdon, Cambridgeshire, United Kingdom).
Real-time quantitative RT-PCR
Presence of AI-H9 viral RNA in the lungs of naive and infected chickens was quantitated using real-time quantitative RT-PCR (Q-RT-PCR). Primer sequences for H9 and chicken GAPDH are depicted in Table 2 . GAPDH is being used as the housekeeping control gene as this molecule proved to be more stable than ␤-actine (data not shown). Eight micrograms of total RNA was reverse-transcribed into cDNA using the Superscript II RT protocol (Invitrogen Life Technologies) in a 30-l reaction. After dilution of the reaction mixture with 15 l H 2 O, 2 l of template cDNA was used for each Q-PCR, which was performed in single wells of a 96-well plate (ABgene, Epsom, Surrey, United Kingdom) in a 50 l reaction volume. The 50 l reaction mixture contained 28. . The software determined a cycle threshold (C t ) value, which identified the first cycle detecting the fluorescence above the baseline for that sample or standard. The GAPDH and H9 PCR-fragments were also cloned and used in combination with the Q-RT-PCR primers to calculate the slopes from log 10 dilution series regression lines. To correct for differences between template RNA levels between samples within an experiment, first the difference factor (DF) (normalization factor) for each sample was calculated by dividing the mean C t value for GAPDH-specific product of a sample by the mean C t value for GAPDH-specific product for all samples. The corrected H9 RNA per sample was calculated using the following formula [15] :
Results are expressed as standardized 40-C t values.
cDNA microarray
Construction of the cDNA libraries, EST sequence analysis, construction of the microarray containing 5007 elements (in duplicate), RNA labeling, hybridizations and data extraction were all performed as described in the paper by Smith et al. [13] . For the hybridizations a reference design approach was used in which all samples from all treatments were pooled and compared with individual treatment samples. The reference and treatment samples were labeled using the dye flip approach, i.e. the reference and treatment samples were crosslabeled and hybridized to two arrays. 
Data analysis
Statistical analysis
Comparison of the levels of up-or down-regulation (microarray data) was performed with the VectorNTI Xpression 3.1 software package (see above). To analyze the Q-PCR and HI-antibody data we used analysis of variance (ANOVA) with least significant difference (L.S.D.) as multiple comparison test. Differences were considered significant at a confidence level of 95% (P < 0.05).
Results
Pathology of H9N2 infection
No evidence of gross clinical pathology was noted in infected animals, similar to earlier unpublished studies with this H9N2 virus (data not shown). The lungs of naive chickens infected with H9N2, similar to those of immune or immune potentiated birds, showed little gross pathology at macroscopic inspection during necropsy (not shown). However, upon microscopic examination by a certified and well-trained pathologist, profound differences were noted in the lungs of non-immune, immune and immune potentiated infected birds at 5 days post-infection (Fig. 2) .
In non-immune infected animals the lungs showed necrosis of parabronchial epithelium, edema, and fibris exudation in airways and air capillaries indicating severe pneumonia (Fig. 2B ). Next to this, diffuse infiltration of lymphoid cells was noticed at higher magnification (not shown). In comparison, the lungs of animals immunized before with H9N2 in saline only (immune infected birds), showed less dramatic fibrinous exudate in the airways (Fig. 2C ) indicating moderate/mild pneumonia, with isolated foci of clustered immune cells (not shown). The airways of chickens immunized with H9N2 antigen formulated in an immunopotentiating W/O delivery system proved minimally affected without obstruction by fibrinous exudate (Fig. 2D) . The lungs showed little recruitment of immune cells and minimal areas of lymphoid cell infiltration at higher magnification (not shown).
Detection of H9N2 virus in naive and immunized hosts
Using quantitative RT-PCR (Q-RT-PCR) employing primers specific for the H9 sequence of avian influenza we noted clear evidence of viral replication at days 1 and 5 in the lungs of non-immune infected birds (Fig. 3) . The lungs from immune animals still showed H9 gene detection especially on day 5. By contrast, immune potentiated animals showed strongly reduced viral replication.
Specific antibody formation in immunized chickens
In blood samples taken 3 weeks post-vaccination, i.e. 1 day before challenge infection, H9N2-specific HI serum antibodies were measured in individual birds of all groups. Immune birds, vaccinated with H9N2 in saline, showed no detectable antibody titers, while immune potentiated animals, vaccinated with H9N2 in a W/O emulsion, showed a readily detectable serum HI titer (Fig. 4) . 
Immunophenotyping of host responses in lung tissue and spleen
In order to obtain more detailed information about immunity-related responses in the lungs and spleen of chickens we used microarray-assisted ex vivo gene expression profiling on lung and spleen tissue isolated at 1 and 5 days after oculo-nasal-intratracheal infection. For this, a reference design combined with a dye flip approach was used (see Section 2.8). Fig. 5 gives an overview of the total amount of significantly (P < 0.05) changed (fold change ≥1.5) genes in the lungs (A-D) and spleens (E-H) between the indicated treatments relative to organs of naive uninfected birds on day 1 and day 5. In the lungs of non-immune infected birds 10.3% ([(202 + 387) − 74]/5007 × 100%) of all genes on the array show a greater than 1.5-fold regulation. This percentage drops to 9.1% and 8.3% in the immune and immune potentiated birds, respectively, suggesting that immune potentiated birds, who received antigen formulated in immunopotentiator, exhibited less immune activation to control the virus, when compared to immune and non-immune birds. For spleen we noted the same phenomena with percentages of 4.0%, 3.1% and 3.1% for nonimmune, immune and immune potentiated birds, respectively. The number of genes, common in the lungs on day 1 and day 5 post-infection, ranges between 74, for the nonimmune birds, and 51, for the immune potentiated birds. Remarkably, only 3 genes are common on day 1 and day 5 in the spleens of immune potentiated birds (13 for the non-immune and 17 for the immune animals). In general, when comparing the gene expression regulation in lung and spleen it is obvious that the spleen is relatively quiet. Subsequently, detailed analysis focussed on genes with an available well-known (putative) immunological annotation, which showed significant (P < 0.05) regulation (fold change ≥1.5). 
Microarray-assisted immunogenomic analysis
Using the reference design approach, we examined significant gene expression differences of non-immune infected, immune infected and immune potentiated infected animals when compared to naive uninfected (saline) hosts. Conspicuous genes in the lungs and spleen, with a well-known immunological annotation, are depicted in Tables 3 and 4 , respectively. Measured gene responses were divided into those associated with known innate immune pathways and genes involved in adaptive immune pathways. As the functional annotation of chicken genes lags dramatically behind similar work achieved in mammals (i.e. mainly mice), we can only assume that most of the chicken genes, which are printed on the micro-array, function in a similar manner as the mammalian molecules. As the chicken genome was released just recently [5] , it may take years before all putative orthologues have been characterized and functionalized. The critical reader should therefore be aware of the fact that if an annotation suggests that a chicken gene is an orthologue it might not function in a similar manner as in mammals.
Innate immune responses 3.5.1.1. Chemokines and receptors.
Chemotactic migration of leukocytes largely depends on adhesive interactions with the substratum and recognition of a chemoattractant gradient provoked by chemokines. Increased expression of the TNF inducible gene SCYa13 (mcp-4 chemokine or small inducible A13 cytokine precursor), was noted on day 1 only in both the lungs and spleens of non-immune and immune infected birds (Tables 3 and 4 ). In the lungs of non-immune and immune infected birds chemokine receptor like protein 2 was also significantly up-regulated at day 1 in both groups, and at day 5 in the non-immune group, while the chemokines AH221 and AH294 (RANTES), but only in the non-immune group, were up-regulated at day 5 only (Table 3 ). In the spleen of immune birds AH221 is up-regulated on day 1 and 5, and only on day 1 in non-immune birds (Table 4) . Remarkably, limited upregulation of chemokines and chemokine receptors was noted in the lungs of immune potentiated infected birds except for the CXCL12 chemokine, which is up-regulated at day 1, and chemokine receptor like protein 2 at day 5 (Table 3) .
Macrophage/myeloid cells.
The scavenger receptor MARCO (macrophage receptor with collagenous structure), a molecule involved in specific recognition and defense against pathogens as well as differentiation of monocytes into dendritic cells, proved selectively expressed at day 1 in non-immune, immune and immune potentiated infected birds, and also at day 5 post-infection in immune potentiated birds (Table 3 ). In MARCO-deficient mice it was shown that this molecule plays an important role in mounting an efficient and appropriately regulated innate immune response against inhaled particles and airborne pathogens [16] .
Toll-pathway.
The recognition of microbes by innate immune cells is crucial for initiation of antigen presentation and down-stream activation of adaptive immune reactions. Toll-like receptors (TLRs) are known to recognize various components of invading pathogens. TLR4, the receptor for bacterial lipopolysaccharide (LPS), is down-regulated in non-immune infected birds at day 1 (Table 3) . Interestingly, TLR2 type 1 [17] , the receptor for bacterial cell wall components, was up-regulated in non-immune and immune infected animals at days 1 and 5, and at day 1 in immune potentiated birds only. The selective up-regulation of TLR2 type 1 expression with concomitant decrease of TLR4 expression at day 1 in non-immune birds maybe due to either influx of distinct innate immune cells, such as antigen presenting cells, or selective regulation of receptor expression on one cell population. TLR2 type 1 is also up-regulated in the spleens of immune birds on day 5 (Table 4 ). In parallel with the up-regulated MARCO receptor and TLR2 type 1 mRNA molecules, all groups showed increased expression of granzyme M, a granular protease associated with NK cells at day 1.
IFN-pathway.
Upon viral infection, production of type-I interferon (IFN) and IFN-induced genes is a typical innate defense response resulting in an antiviral state of noninfected neighboring target cells. Type I IFN is also known to act as an important immune inducer and immunoregulatory factor. A number of genes associated with an activated type I IFN-pathway were noted especially in the lungs of non-immune and immune infected chickens (Table 3) . Activated genes included IFN associated IRF4/MUM1 (interferon regulatory factor 4), -also involved in controlling B-cell proliferation and differentiation, and proliferation of mitogen-activated T cells -showed similar up-regulation at days 1 and 5 after infection in non-immune and immune hosts (Table 3 ). In addition, type I IFN-pathway transcription factor IRF8, showed up-regulation specific for lungs of chickens immunized with antigen only at days 1 and 5 after infection and in immune potentiated birds at day 1 ( Table 3 ). The IFN-induced protein IFP35 showed selectively increased expression at day 1 in the lungs and spleens of nonimmune and immune infected birds (Tables 3 and 4) . The IFN pathway genes IFP35, IRF4 and IRF8 noted in lungs of chickens receiving antigen only (immune infected), suggest that viral replication was not completely blocked as a result of immunization with antigen in saline only. This hypothesis is consistent with Q-PCR detection of the viral haemagglutinin gene (see above). However, in H9N2-infected chickens immunized with antigen in immunopotentiating adjuvant, the immune potentiated group, only IRF4 and IRF8 were upregulated, on days 5 and 1, respectively (Table 3) .
Heat shock proteins (HSPs).
The main function of heat shock proteins (HSPs) is to act as chaperones of nascent or abnormally folded proteins. However, from an immunological point of view HSPs have obtained increasing interest since they may act as endogenous immune-activating "danger" signals. Hsp70 and Hsp90␣ expression was clearly up-regulated at days 1 and 5 in immune potentiated birds (Table 3) , while Hsc70II showed up-regulation in, especially lungs of, non-immune chickens on day 1.
Complement factors.
The complement system consists of several plasma proteins, i.e. complement factors, that act together to attack extracellular pathogens. Up-regulation of complement C3 mRNA was noted only in non-immune infected birds at day 5 and in immune and immune potentiated infected birds at day 1 (Table 3) . Complement inhibitory factor H was down-regulated in non-immune animals on day 1 after challenge only. Remarkably, in spleens of non-immune and immune infected birds, but not in immune potentiated animals, complement C1 proteins, i.e. C1r-like and C1qB, are commonly up-regulated (Table 4) .
Pro-inflammatory cytokines.
Secretion of proinflammatory cytokines, such as tumor necrosis factor (TNF), interleukin (IL-1) and IL-6, is one of the early reactions of the host against infection. A combined action of these cytokines causes fever, leukocytosis and the production of acute phase proteins. At 1 day after infection, lungs of non-immune and immune infected birds, show up-regulated gene expression of interleukin-6 (IL-6) (Table 3) . However, expression of this pro-inflammatory cytokine was not altered in the lungs of immune potentiated animals.
Adaptive immune responses 3.5.2.1. Antigen presentation.
Increased antigen presentation to CD8 positive T cells was suggested by the upregulation of class I alpha, class B-F heavy and class I minor chains at day 5 after challenge in the lungs of nonimmune birds. This was, to a lower extent, also observed in lungs of immune and immune potentiated animals (Table 3) .
Cathepsin S, a key protease responsible for the removal of the invariant chain from MHC class II molecules, is up-regulated at day 1 in the lungs and spleens of non-immune and immune infected birds. However, at day 5 cathepsin S is only upregulated in the spleens of immune and immune potentiated birds (Tables 3 and 4) .
CD markers and cytokine receptors.
Up-regulated expression of T cell-specific CD3 genes was noted in lungs of non-immune and immune infected birds at days 1 and 5 and in immune potentiated birds at day 5 only (Table 3) . Remarkably, increased expression of CD4 and CD8 was evident especially in immune birds at day 1. These animals also showed evidence of active up-regulation of cytokine receptor expression, such as IL-2Rb on day 5, IL-13R2 on days 1 and 5, and IFN-␥R2 on day 1 (Table 3) . Up-regulation of the cytokine receptors IL-13R2 and IFN-␥R2 was also noted on day 1 in spleens of immune and non-immune birds, respectively (Table 4) . Immune potentiated infected birds showed no evidence of increased cytokine receptor expression in lungs and spleen. Interestingly, no significant changes in the corresponding cytokine genes, such as IL-2, IFN-␥ and IL-4, were noted in any group on any point in time in lungs and spleens when using the micro-array approach. Unfortunately, the genes encoding IL-13, an important Th-2 cytokine, and IL-20, a member of the IL-10 family of molecules associated with putative regulatory T cell function, are not included on this version of the microarray.
Transcription factors.
At day 1 after infection lungs of non-immune and immune birds, and spleens of immune birds, show up-regulation of GATA-3, which is associated with Th-2 type T cell immune responses in mammals (Tables 3 and 4 ). Lungs and spleens of immune potentiated infected birds showed no altered GATA-3 gene expression at any time-point. However, an increased expression of cystatin F (leukocystatin) an immune cell restricted cysteine proteinase inhibitor, which may play a role in antigen presentation [18] , was observed at day 1 in lungs only (Table 3) .
B cells.
Influx onto or (re)activation of B cells in infected lungs was suggested by the up-regulation of the genes encoding various Ig chains especially at 5 days after infection of non-immune, immune and immune potentiated animals (Table 3 ). In all groups Ig chain expression concurred with increased expression of CD5, a mammalian marker of many B-1a but also B-2 B cells. The profound increase of CD5 in immune birds on day 5 may be explained by a booster effect as a result of the challenge infection. For immune potentiated birds the level of responsiveness was more modest, likely in view of pre-existing virus-neutralizing antibodies in the circulation, which may immediately neutralize (part of) the challenge infection.
Apoptosis and TNF-related gene expression.
Influenza virus has been shown to induce apoptosis in cells that are permissive for viral replication and cells that do not support viral replication. Influenza induced apoptosis likely represents part of an overall beneficial immune response, but, on the other hand, could also be a mechanism involved in disease pathogenesis. In our study, granzyme M, a representative of a new perforin-dependent cell death pathway playing a significant role in cell death mediated by NK cells [19] , is up-regulated at day 1 after infection in the lungs of all groups (Table 3 ). In addition, the anti-apoptotic protein NR13, a member of the Bcl-2 family, is up-regulated at day 5 in immune infected lungs which co-incides with upregulation of granzyme M. TRAF-1 (tumor necrosis factorreceptor associated factor-1) is an adaptor and signal transduction molecule known to interact with the cytoplasmic tail of TNF receptor 2 thereby linking it to different signal transduction pathways. TRAF1 inhibits antigen-induced apoptosis in CD8 + lymphocytes [20] . This molecule showed increased expression in lungs of non-immune chickens at 5 days after infection (Table 3 ). This coincided with upregulation of MHC class I chain genes. TRAF2 and TRAF5 showed up-regulation at day 1 in lungs of immune infected birds, coinciding with CD3, CD4, CD8 and the FASL decoy receptor 3 and death receptor 6 expression. Again, lungs of immune potentiated infected birds showed no TRAF1, TRAF2 or TRAF5 expression.
Discussion
Influenza virus infections may cause inflammatory pneumonia in all susceptible species. Control of an acute influenza virus infection in naive hosts is thought to be based on innate and subsequent adaptive cytotoxic T lymphocyte (CTL) and B cell activity [21, 22] . By contrast, readily available virus neutralizing antibodies are believed to be largely responsible for protection of immunized hosts, but not essential [22] , as demonstrated in murine models. However, the precise role of host immune elements in the control of acute avian influenza is unknown. In addition, the potential contribution of host immune elements in pulmonary immunopathology in birds is largely undefined. In this study we investigated the influence of a respiratory infection of inbred broiler chickens with the low pathogenic avian influenza H9N2 virus on lung pathology and gene expression. We demonstrate for the first time lung pathology (pneumonia) of the low pathogenic H9N2 virus and insights into the molecular interaction with its naive natural host. In addition we examined molecular early host responses to respiratory influenza A H9N2 virus infection in immunized chickens infected via the respiratory route.
When considering the observed levels of virus-inhibiting antibodies, as well as histopathology and viral Q-PCR data, we anticipated that immune potentiated birds, immunized with formalin-inactivated antigen formulated in W/O immunopotentiator, needed less immune activation in their lungs to control the virus, when compared to immune birds, receiving antigen only. Conversely, in view of the observed immunopathology in the lungs and absence of antiviral antibodies at the moment of infection we foresaw more vigorous immune responsiveness following pulmonary infection of non-immune birds, which exhibited viral Q-PCR positive lungs.
Indeed, the patterns of gene expression noted in the different groups suggest most intense reactions in non-immune animals, with a partial overlap in the immune birds immunized with inactivated antigen in saline only. Similar to our naive H9N2 infected chickens, the lungs of H1N2 infected macaques, when analyzed by microarrays, showed induction of IFN and B cell activation pathways, though with more overt clinical signs [23] . By contrast, immune potentiated chickens showed insignificant responses for a number of known innate and adaptive immune elements that were noted in the less immune and naive birds, including TNF-and apoptosis-related genes as well as proinflammatory IL-6, and certain chemokines. Remarkably, in this immune potentiated group no significant changes in any known immunoregulatory cytokine or cytokine receptor gene were noted at any point in time.
Based largely on studies in mice, the first line of defense against influenza virus has been shown to involve natural antibodies produced by B-1 cells [24] , which do not increase IgM production nor proceed to immunoglobulin isotype switching. Indeed, we noted up-regulated expression of CD5, a marker of many B-1a cells in mammals, in the lungs of all groups at day 5. In addition, granulocytes, such as neutrophils, are prominent in acutely infected murine lungs and believed to control initial viral replication. Indeed, granzyme M, an NK cell specific protease was significantly expressed at day 1 in the lungs of all groups. Recent studies in IL-1 receptor deficient mice, however, suggest no major contribution for neutrophils in the clearance of influenza [25] . We noted no increased expression of chicken IL-1 mRNA in any of the treated groups. However, increased expression of IL-6, another pro-inflammatory mediator, was noted in lungs of non-immune and immune (antigen-primed) birds at day 1 only.
As yet, the gene encoding for tumor necrosis factor alpha (TNF-␣) has not been identified in the chicken and is therefore not available for monitoring. However, TRAF1, TRAF2, TRAF5, the TNF family member Death receptor 6 and the FasL decoy receptor 3, showed up-regulation especially in lungs of immune birds. In mice TNF-␣ is involved in recruitment of inflammatory cells to the lung and the severity of disease, while leaving virus clearance unaffected [26] . In the same model the initiation of infection-induced lung injury proved to depend on TNF-␣ expressed by Ag-specific CD8+ T cells, recognizing Ag expressed by alveolar epithelial cells [27] . TNF-␣ neutralization in vivo or TNF receptor (p55) gene deletion inhibited weight loss and lethality [27] . This was associated with minimal macrophage infiltration and reduced expression of the murine monocyte chemokine attractant gene-1 (MCP-1), at least one of the chemokines produced by target epithelial cells [27] . In vivo neutralization of MCP-1 significantly reduced inflammation and immunopathology. In our studies evidence for macrophage gene expression was noted for MARCO in the lungs of nonimmune, immune and immune potentiated infected birds at day 1, and also at day 5 in immune potentiated birds (Table 3) . The chemokine AH294 (RANTES), which is produced by influenza infected epithelial cells [28] , and selectively upregulated especially in non-immune infected lungs at day 5 (Table 3) , has been reported to facilitate activation and extravasation of macrophages [29] . Genes associated with MHC class I presentation were evident especially in the nonimmune infected group at day 1 and day 5, but less prominent, and possibly less needed, in the immune and immune potentiated group.
Collectively, our microarray data show that in all groups IFN pathway genes are evident, although somewhat less in immune potentiated birds, possibly explained by inhibited viral replication. The up-regulation of IFN pathway genes suggests that expression of these genes may be important in initiating the antiviral response. Remarkably, however, we could neither detect MX (a protein induced by IFN that inhibits influenza virus and which is highly polymorphic in chicken) nor IFN-␥. In addition, all groups show upregulated genes involved in MHC-class I presentation, CD5 and B cell immunoglobulin genes. Up-regulation of MHC class I genes on day 5 are typical for lungs of non-immune infected birds. Certain innate and adaptive immune reactions are overlapping in both non-immune infected birds as well as immune infected chickens, as reflected by up-regulated chemokine receptor expression, and expression of TLR2 type 1, IFP35, IRF4, IL-6 as well as GATA-3. When compared to other groups the lungs of chickens immunized with antigen in saline only (immune), show relatively more CD marker genes, IL-13R2, IFN-␥R2 and IL-2R2, hence more evidence for adaptive immunoregulation pathways, as well as TNF and apoptosis-related genes. By contrast, in the lungs of immune potentiated birds innate response genes are rather limited except for certain heat shock proteins, granzyme M and MARCO, which, together with circulating antibodies and T cells, are likely sufficient to control the challenge infection. Remarkably, in the spleens of immune potentiated birds regulation of innate and adaptive immune response genes are limited to only cathepsin S up-regulation at day 5.
Studies in mice revealed that in general Th-1 type immunity involving IFN-␥ producing T helper 1 cells [30] and CD8 + CTL [31] are involved in the control of pulmonary influenza infection. However, the pulmonary environment generally promotes type-2 immune reactions [32] . Nasalpulmonary immunization of BALB/C mice with influenza antigen alone induces increased Th-2 cytokine mRNA expression (IL-4 and IL-5) in lung lymphocytes, which are mainly CD4+ cells, but with no differences in Th-1 cytokine mRNA (IFN-␥ and IL-2) expression [32] . Conflicting murine data exist on the role of IL-18. While in one study intranasal influenza virus infection of IL-18 deficient mice resulted in increased mortality as a result of reduced IFN-␥ levels and poor NK cell activation [33] , Van der Sluis et al. [34] showed that IL-18 deficient mice had reduced viral loads and enhanced CD4+ T cell activation and normal IFN-␥ levels monitored by intracellular staining. Interestingly, however, studies in mice with null mutations of the receptors for IFN-␣/␤, IFN-␥ or both IFNs showed no major differences in the control of acute or secondary intranasal influenza virus infection [21] , suggesting a general redundancy of the IFN system to pulmonary influenza immunity. Also, IFN-␥ deficient mice show almost no impaired resistance to intranasal influenza infection [35] , a skewing towards Th-2 characteristic IL-4 and IL-5 production and associated IgG1 antibody isotype. Our microarray data revealed profound up-regulation of the Th-2 response associated IL-13R2 and GATA-3 genes, but unfortunately no clear evidence for selective recruitment or activation of Th-1 or Th-2 polarized cytokines, possibly to a lack of detection sensitivity. Some key Th-2 associated chicken cytokine genes like IL-13 and IL-4 were unknown until very recently and only IL-4 is fortunately included on this version of the microarray; although not significantly regulated.
In summary, respiratory infection using H9N2 influenza A virus is useful to study respiratory immune reactions to low-pathogenic influenza virus in lungs and spleen of naive or immunized chickens. Evaluation of our preliminary microarray data suggests gene pathways unique to or common among the differently immune groups. In that respect prominent class I presentation genes are typical in lungs of non-immune infected birds. Both non-immune and immune (antigen only) infected birds show similarities in lung expression of chemokines, TLR2 type 1, and IL-6. All groups showed up-regulation of IFN pathway genes, together with genes involved in MHC class I antigen presentation, as well as genes encoding CD5 and Ig. In the lungs of immune potentiated birds we noted minimal innate responses, limited to HSPs, which, likely together with existing antibodies and effectively primed T cells, are sufficient to control the pulmonary infection. Also, in the spleens of immune potentiated birds well-known immune responses at the molecular level are not detectable. Lungs of birds that received antigen only (immune) typically show prominent expression of CD4 and CD8 genes, as well as genes encoding IL-13R, IFN␥R, TRAF2 and TRAF5. Further in vivo studies addressing the functional contribution of selected up-regulated gene products, their association with certain cell types and transcriptional regulation will help to delineate influenza virusinduced immunopathology and (cross-protective) immunity. Such information may reveal new targets for disease intervention in the natural host or may provide a model for other species including man.
